How We Evaluate Evidence
Brain fog research spans from robust clinical trials to emerging case reports. We use a transparent grading system so you know the strength of evidence behind each claim.
This is our own simplified editorial scale. It is not the formal GRADE framework and it is not a substitute for guideline-level evidence review. We use it to make the site easier to read, not to impersonate a standards body.
Why Evidence Grading Matters
Not all research is created equal. A single case study of 5 people tells a different story than a meta-analysis of 50 randomized controlled trials involving thousands of participants.
By showing you the evidence tier for each claim, we help you make informed decisions about what to prioritize - and what to discuss with your healthcare provider before trying.
This approach follows principles from evidence-based medicine and aims to be transparent about what we know, what we think we know, and what remains uncertain.
How This Maps To Formal Frameworks
Our A-D labels are a shorthand for readers. They roughly line up with how a formal framework would think about evidence strength, but they are not a one-to-one conversion.
A: Usually guideline-level, replicated trial-level, or strong systematic-review support.
B: Usually decent human evidence with real signal, but fewer studies, smaller studies, or more uncertainty than A-tier claims.
C: Early or limited human evidence that may be useful but should not be oversold.
D: Mechanistic, expert-informed, or observational clues that may help frame questions, not settle them.
If you need a formal grading system for clinical decision-making, use the underlying guidelines and systematic reviews directly.
Our Evidence Tiers
Strong Evidence
Highest confidence level
Claims backed by multiple high-quality studies with consistent findings.
What qualifies:
- Meta-analyses or systematic reviews of RCTs
- 3+ large randomized controlled trials with consistent results
- Strong observational studies with biological plausibility
- Established clinical guidelines (NICE, ATA, etc.)
Moderate Evidence
Good support, some limitations
Promising research with methodological strengths, but not yet definitive.
What qualifies:
- 1-2 well-designed RCTs
- Large observational/cohort studies
- Consistent findings across multiple smaller studies
- Mechanistic evidence with clinical correlation
Preliminary Evidence
Early research, needs confirmation
Interesting findings that need more research before drawing strong conclusions.
What qualifies:
- Small pilot studies (n < 50)
- Case series with consistent patterns
- Animal or in vitro studies with human relevance
- Single observational studies
Emerging / Theoretical
Early-stage or expert opinion
Theoretical basis or clinical observations not yet studied formally.
What qualifies:
- Case reports (individual patients)
- Expert clinical experience/consensus
- Mechanistic plausibility without clinical studies
- Patient-reported outcomes from surveys
Our Research Process
Primary Source Review
We search PubMed, Cochrane Library, and clinical guideline databases for peer-reviewed research. We prioritize recent publications (last 10 years) while including foundational older studies.
Study Quality Assessment
We evaluate study design, sample size, methodology, and potential conflicts of interest. Randomized controlled trials carry more weight than observational studies.
Consistency Check
We look for replication across multiple studies and research groups. Isolated findings receive lower tier ratings until confirmed.
Citation & Transparency
We provide DOI links and PubMed IDs wherever possible so you can verify sources yourself. When evidence is limited, we say so explicitly.
Limitations & Caveats
- - Brain fog is not a formal diagnosis, so research often uses related terms like "cognitive dysfunction" or "mental fatigue"
- - Some conditions (Long COVID, ME/CFS) have limited research due to historical underfunding
- - Individual responses vary - what works statistically may not work for everyone
- - We update content as new research emerges, but there may be delays
- - This is educational content, not medical advice - often consult your healthcare provider
Questions About Our Research?
If you notice an error, outdated information, or have questions about our evidence grading, we want to hear from you. Accuracy matters.
[email protected]